Nov 13,2020 03:00 PM
Of the total PLI scheme, an outlay of Rs15,000cr is set for pharmaceuticals and drugs sector.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||520.15||43.29||124,741.43||724.81||0.77||3,207.24||106.10|
|Divis Laboratories Ltd||3,537.05||53.44||93,958.62||513.30||0.45||1,713.78||313.47|
|Dr Reddys Laboratories Ltd||4,915.50||33.25||81,661.83||481.00||0.51||3,333.60||979.45|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Sun Pharmaceutical Industries Ltd. is the fifth largest speciality generic pharmaceutical company in the world. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingred... More
Reports by sun-pharmainds
Nov 25, 2020
Sun Pharmaceuticals (Sun Pharma), India’s largest pharma company by revenue is making slow progress in its US specialty business which is unlikely to negate pricing pressure in generic business; rec...More
Nov 25, 2020 02:03 AM
The company’s consolidated revenue stood at Rs8,259.30cr, up 15.7% yoy and 17.2% qoq.
03 Nov 2020
21 Oct 2020
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the... More
27 Aug 2020
31 Jul 2020
AGM 27/08/2020This is to inform you that the 28th Annual General Meeting of the shareholders of the ... More
27 May 2020
19 Aug 2020
As per file attached... More